UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Spatial-seasonal characteristics and critical impact factors of PM2.5 concentration in the Beijing-Tianjin-Hebei urban agglomeration

PloS one, 2018-09, Vol.13 (9), p.e0201364-e0201364

2018

Volltextzugriff (PDF)

Multiple myeloma hinders erythropoiesis and causes anaemia owing to high levels of CCL3 in the bone marrow microenvironment

Scientific reports, 2020-11, Vol.10 (1), p.20508-14, Article 20508

2020

Volltextzugriff (PDF)

Complex network analysis of global stock market co-movement during the COVID-19 pandemic based on intraday open-high-low-close data

Financial innovation (Heidelberg), 2024-12, Vol.10 (1), p.7-50, Article 7

2024

Volltextzugriff (PDF)

What influences the urban sewage discharge in China? The effect of diversified factors on the urban sewage discharge in different regions of China

Environment, development and sustainability, 2022-05, Vol.24 (5), p.6099-6135

2022

Volltextzugriff (PDF)

A structural VAR and VECM modeling method for open-high-low-close data contained in candlestick chart

Financial innovation (Heidelberg), 2024-12, Vol.10 (1), p.97-29, Article 97

2024

Volltextzugriff (PDF)

Monitoring the cytogenetic architecture of minimal residual plasma cells indicates therapy-induced clonal selection in multiple myeloma

Leukemia, 2020-02, Vol.34 (2), p.578-588

2020

Volltextzugriff (PDF)

Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma

The Journal of clinical investigation, 2022-02, Vol.132 (3), p.1-18

2022

Volltextzugriff (PDF)

Favorable outcomes of front-line risk-adapted therapy in young patients with diffuse large B-cell lymphoma with clinically or biologically high-risk features

Chinese medical journal, 2024-07, Vol.137 (13), p.1620-1622

2024

Volltextzugriff (PDF)

Rituximab plus cyclophosphamide and dexamethasone versus bortezomib plus cyclophosphamide and dexamethasone in newly diagnosed symptomatic Waldenström macroglobulinemia: a randomized controlled trial

Haematologica (Roma), 2024-05, Vol.109 (5), p.1614

2024

Volltextzugriff (PDF)

Acute pancreatitis in pregnancy: a 10-year, multi-center, retrospective study in Beijing

BMC pregnancy and childbirth, 2022-05, Vol.22 (1), p.414-9, Article 414

2022

Volltextzugriff (PDF)

High incidence of MYD88 and KMT2D mutations in Chinese with chronic lymphocytic leukemia

Leukemia, 2021-08, Vol.35 (8), p.2412-2415

2021

Volltextzugriff (PDF)

Real-world treatment patterns, discontinuation and clinical outcomes in patients with B-cell lymphoproliferative diseases treated with BTK inhibitors in China

Frontiers in immunology, 2023-07, Vol.14, p.1184395

2023

Volltextzugriff (PDF)

Pegfilgrastim improves the outcomes of mobilization and engraftment in autologous hematopoietic stem cell transplantation for the treatment of multiple myeloma

Annals of hematology, 2020-06, Vol.99 (6), p.1331-1339

2020

Volltextzugriff (PDF)

Studies on the Termination Behavior of Styrenic Free‐Radicals

ChemistrySelect (Weinheim), 2024-08, Vol.9 (31), p.n/a

2024

Volltextzugriff (PDF)

Purine nucleoside analogs plus rituximab are an effective treatment choice for hairy cell leukemia-variant

Annals of hematology, 2022-06, Vol.101 (6), p.1201-1210

2022

Volltextzugriff (PDF)

Minimal residual disease status improved the response evaluation in patients with Waldenström's macroglobulinemia

Frontiers in immunology, 2023-05, Vol.14, p.1171539-1171539

2023

Volltextzugriff (PDF)

Indirubin-3’-monoxime acts as proteasome inhibitor: Therapeutic application in multiple myeloma

EBioMedicine, 2022-04, Vol.78, p.103950-103950, Article 103950

2022

Volltextzugriff (PDF)

Dynamic monitoring of circulating tumor DNA reveals outcomes and genomic alterations in patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy

Journal for immunotherapy of cancer, 2024-03, Vol.12 (3), p.e008450

2024

Volltextzugriff (PDF)

Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma

Journal for immunotherapy of cancer, 2024-04, Vol.12 (4), p.e008857

2024

Volltextzugriff (PDF)

Sequential treatment escalation improves survival in patients with Waldenstrom macroglobulinemia

Blood science, 2024-01, Vol.6 (1), p.e00179-e00179

2024

Volltextzugriff (PDF)

P1162: FRONT‐LINE RISK‐ADAPTED THERAPY PRESENTED FAVORABLE OUTCOMES FOR YOUNG PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA: RESULTS FROM A CONSECUTIVE COHORT IN CHINA

HemaSphere, 2023-08, Vol.7 (S3), p.e347322d-n/a

2023

Volltextzugriff (PDF)

Reduced ABO blood group antibody titers in patients after CD19 CAR-T cell therapy

Blood science, 2023-01, Vol.5 (1), p.62-65

2023

Volltextzugriff (PDF)

Benefit of rituximab maintenance is associated with Follicular Lymphoma International Prognostic Index in patients with follicular lymphoma

Blood science, 2023-04, Vol.5 (2), p.118-124

2023

Volltextzugriff (PDF)

A pseudo principal component analysis method for multi-dimensional open-high-low-close data in candlestick chart

Communications in statistics. Theory and methods, 2024-05, Vol.53 (10), p.3472-3498

2024

Volltextzugriff (PDF)

Fast or slow system: How does information exposure affect individual climate change mitigation responses?

Urban climate, 2024-07, Vol.56, p.102071, Article 102071

2024

Volltextzugriff (PDF)

1 – 25 von 246

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(217)
Mit Volltextzugriff
(219)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(169)
Life Sciences & Biomedicine
(94)
Physical Sciences
(49)
Technology
(42)
Humans
(40)
Chemistry
(33)
Engineering
(28)
Science & Technology - Other Topics
(28)
Chemistry, Multidisciplinary
(24)
Female
(24)
Male
(23)
Oncology
(19)
Animals
(18)
Hematology
(16)
Middle Aged
(16)
Multidisciplinary Sciences
(16)
Adult
(14)
Environmental Sciences
(14)
Environmental Sciences & Ecology
(14)
Proteins
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Spatial-seasonal characteristics and critical impact factors of PM2.5 concentration in the Beijing-Tianjin-Hebei urban agglomeration

Multiple myeloma hinders erythropoiesis and causes anaemia owing to high levels of CCL3 in the bone marrow microenvironment

Complex network analysis of global stock market co-movement during the COVID-19 pandemic based on intraday open-high-low-close data

What influences the urban sewage discharge in China? The effect of diversified factors on the urban sewage discharge in different regions of China

A structural VAR and VECM modeling method for open-high-low-close data contained in candlestick chart

Monitoring the cytogenetic architecture of minimal residual plasma cells indicates therapy-induced clonal selection in multiple myeloma

Genomic and transcriptomic profiling reveals distinct molecular subsets associated with outcomes in mantle cell lymphoma

Favorable outcomes of front-line risk-adapted therapy in young patients with diffuse large B-cell lymphoma with clinically or biologically high-risk features

Rituximab plus cyclophosphamide and dexamethasone versus bortezomib plus cyclophosphamide and dexamethasone in newly diagnosed symptomatic Waldenström macroglobulinemia: a randomized controlled trial

Acute pancreatitis in pregnancy: a 10-year, multi-center, retrospective study in Beijing

High incidence of MYD88 and KMT2D mutations in Chinese with chronic lymphocytic leukemia

Real-world treatment patterns, discontinuation and clinical outcomes in patients with B-cell lymphoproliferative diseases treated with BTK inhibitors in China

Pegfilgrastim improves the outcomes of mobilization and engraftment in autologous hematopoietic stem cell transplantation for the treatment of multiple myeloma

Studies on the Termination Behavior of Styrenic Free‐Radicals

Purine nucleoside analogs plus rituximab are an effective treatment choice for hairy cell leukemia-variant

Minimal residual disease status improved the response evaluation in patients with Waldenström's macroglobulinemia

Indirubin-3’-monoxime acts as proteasome inhibitor: Therapeutic application in multiple myeloma

Dynamic monitoring of circulating tumor DNA reveals outcomes and genomic alterations in patients with relapsed or refractory large B-cell lymphoma undergoing CAR T-cell therapy

Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma

Sequential treatment escalation improves survival in patients with Waldenstrom macroglobulinemia

P1162: FRONT‐LINE RISK‐ADAPTED THERAPY PRESENTED FAVORABLE OUTCOMES FOR YOUNG PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA: RESULTS FROM A CONSECUTIVE COHORT IN CHINA

Reduced ABO blood group antibody titers in patients after CD19 CAR-T cell therapy

Benefit of rituximab maintenance is associated with Follicular Lymphoma International Prognostic Index in patients with follicular lymphoma

A pseudo principal component analysis method for multi-dimensional open-high-low-close data in candlestick chart

Fast or slow system: How does information exposure affect individual climate change mitigation responses?

Aktive Filter

Suchergebnisse filtern